Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022094671 - CANNABINOID ENCAPSULATION TECHNOLOGY

Publication Number WO/2022/094671
Publication Date 12.05.2022
International Application No. PCT/AU2021/051313
International Filing Date 05.11.2021
IPC
A61K 31/352 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/05 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 31/575 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
575substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
A61K 36/185 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
A61K 47/36 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 9/50 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
50Microcapsules
Applicants
  • ZELIRA THERAPEUTICS OPERATIONS PTY LTD [AU]/[AU]
Inventors
  • TAKECHI, Ryu
  • MAMO, John
  • MOORANIAN, Armin
  • MAJIMBI, Maimuna
  • BROOK, Emily
  • AL-SALAMI, Hani
Agents
  • GRIFFITH HACK
Priority Data
202090405706.11.2020AU
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) CANNABINOID ENCAPSULATION TECHNOLOGY
(FR) TECHNOLOGIE D'ENCAPSULATION DE CANNABINOÏDES
Abstract
(EN) The invention relates to a composition comprising one or more cannabinoids, a permeation enhancer, and an alginate polymer, wherein the one or more cannabinoids and permeation enhancer are encapsulated. Such compositions may be useful in the treatment of neurodegenerative disorders, where delivery of a cannabinoid to the brain is required.
(FR) L'invention concerne une composition comprenant un ou plusieurs cannabinoïdes, un activateur de perméation et un polymère d'alginate, le ou les cannabinoïdes et l'activateur de perméation étant encapsulés. De telles compositions peuvent être utiles dans le traitement de troubles neurodégénératifs, dans lesquels l'administration d'un cannabinoïde au cerveau est requise.
Latest bibliographic data on file with the International Bureau